Cell Therapy

UCB Paid $1.15B for Neurona's Single-Dose Epilepsy Cell Therapy

UCB paid up to $650m upfront, with up to $500m in future milestones, to buy Neurona Therapeutics in a deal valued at up to $1.15bn.